Hemangiosarcoma clinical trials
The registry lists 58 studies for Hemangiosarcoma across more than 10 countries. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-17.
Status
- Completed
- 28
- Recruiting
- 12
- Terminated
- 6
- Active, not recruiting
- 4
- Withdrawn
- 4
- Status unknown
- 3
Phase
- Phase 2
- 38
- Phase 1
- 10
- Phase 3
- 2
- Phase 4
- 1
Where
- United States
- 31
- France
- 9
- United Kingdom
- 5
- Canada
- 2
- Spain
- 2
- Italy
- 2
Who runs them
National Cancer Institute (NCI) (7) · M.D. Anderson Cancer Center (3) · Centre Oscar Lambret (3) · Memorial Sloan Kettering Cancer Center (2) · Children's Oncology Group (2) · Northwestern University (2) · OHSU Knight Cancer Institute (2) · Agenus Inc. (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 58 — search for more.
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsRecruitingNCT06440005Phase 11 country
- Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for AngiosarcomaRecruitingNCT06898970Phase 21 country
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 11 country
- NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)RecruitingNCT06239272Phase 1/21 country
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerRecruitingNCT01042379Phase 21 country
- Agnostic Therapy in Rare Solid TumorsRecruitingNCT06638931Phase 21 country
- Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma PatientsRecruitingNCT074329321 country
- Cardiac Angiosarcoma International RegistryRecruitingNCT067155791 country
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable1 country
- IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)RecruitingNCT06849986Phase 21 country
- Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStarsRecruitingNCT063759411 country
- MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaRecruitingNCT06277154Phase 21 country
- Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone SarcomasNot yet recruitingNCT05515068
- Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by SurgeryCompletedNCT00874874Phase 21 country
- Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)CompletedNCT03331250Phase 21 country
- A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallyTerminatedNCT05826600Phase 1/23 countries
- Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer StudyTerminatedNCT05026736Phase 21 country
- Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic SarcomaActive, not recruitingNCT04668300Phase 21 country
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 22 countries
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerActive, not recruitingNCT03860272Phase 12 countries
- Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced AngiosarcomasCompletedNCT01303497Phase 21 country
- Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous AngiosarcomaWithdrawnNCT05799612Phase 1
- A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization ProceduresCompletedNCT02625389Phase 41 country
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT065359971 country
- A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMAActive, not recruitingNCT05601232Phase 21 country
- Cemiplimab for Secondary AngiosarcomasCompletedNCT04873375Phase 21 country
- Propranolol in AngiosarcomaCompletedNCT04518124Phase 21 country
- Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaCompletedNCT02584309Phase 21 country
- Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the SkinTerminatedNCT057294251 country
- Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryCompletedNCT03009201Phase 11 country
- A Study of Oraxol in Subjects With Cutaneous AngiosarcomaCompletedNCT03544567Phase 24 countries
- Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and AngiosarcomaCompletedNCT04293289Not applicable1 country
- Study of T-VEC in Locally Advanced Cutaneous AngiosarcomaTerminatedNCT03921073Phase 21 country
- Pazopanib Hydrochloride in Treating Patients With Advanced AngiosarcomaCompletedNCT01462630Phase 21 country
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaCompletedNCT00346164Phase 35 countries
- Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced AngiosarcomaCompletedNCT02048722Phase 21 country
- Evaluation of Votrient in AngiosarcomaTerminatedNCT02212015Phase 22 countries
- AGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable AngiosarcomaWithdrawnNCT04607200Phase 2
- Phase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWithdrawnNCT05116800Phase 21 country
- Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue SarcomaCompletedNCT01532687Phase 21 country
- A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasWithdrawnNCT04906876Phase 21 country
- A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue SarcomasCompletedNCT01140737Phase 21 country
- Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced AngiosarcomaCompletedNCT02979899Phase 38 countries
- Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory SarcomaCompletedNCT01614795Phase 22 countries
- Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1/21 country
- Paclitaxel-Avelumab for AngiosarcomaStatus unknownNCT03512834Phase 21 country
- Bevacizumab in Treating Patients With AngiosarcomaCompletedNCT00288015Phase 21 country
- Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable AngiosarcomaTerminatedNCT01055028Phase 21 country
- Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic CorrelationCompletedNCT030254381 country
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaCompletedNCT00112463Phase 2